Chronic kidney disease (CKD) has become a major global health concern, with millions of people progressing to end-stage renal disease (ESRD), where kidney function declines to the point that renal replacement therapy becomes essential for survival. Peritoneal dialysis has emerged as an effective and patient-centered treatment option, offering greater flexibility and enabling many patients to receive dialysis at home. The increasing demand for advanced renal replacement therapies is driving the growth of the end stage renal disease (ESRD) treatment market, the automated peritoneal dialysis (APD) market, and the continuous ambulatory peritoneal dialysis (CAPD) market, supporting the continued expansion of the Peritoneal Dialysis Market.

The global Peritoneal Dialysis Market was valued at USD 9.43 billion in 2024 and is projected to grow from USD 9.95 billion in 2025 to USD 16.44 billion by 2034, registering a CAGR of 5.7% during the forecast period (2025–2034).

Rising Demand in the End Stage Renal Disease (ESRD) Treatment Market

The growing end stage renal disease (ESRD) treatment market is largely driven by the increasing burden of diabetes, hypertension, obesity, and aging populations, all of which are major risk factors for chronic kidney disease. As more patients progress to ESRD, the need for effective renal replacement therapies continues to rise.

Peritoneal dialysis has become an attractive alternative to hemodialysis for many patients because it offers greater independence, fewer hospital visits, and improved quality of life. The therapy uses the patient's peritoneal membrane as a natural filter to remove waste products and excess fluid from the bloodstream.

Healthcare providers increasingly recommend peritoneal dialysis for eligible patients due to its clinical effectiveness, lower infrastructure requirements, and ability to support long-term home-based care.

Automated Peritoneal Dialysis (APD) Market Driving Innovation

The automated peritoneal dialysis (APD) market has experienced rapid growth as technological advancements make dialysis treatment more convenient and efficient. APD uses an automated cycler machine that performs multiple dialysis exchanges during the night while patients sleep.

Key advantages of APD include:

• Greater convenience for patients with active lifestyles
• Reduced daytime treatment interruptions
• Improved treatment adherence
• Enhanced fluid management
• Increased patient comfort

Modern APD systems incorporate digital monitoring capabilities, remote patient management, and user-friendly interfaces that improve treatment accuracy and allow healthcare providers to monitor therapy outcomes from a distance.

The integration of connected health technologies is further supporting the expansion of the Peritoneal Dialysis Market by enabling personalized care and reducing hospital admissions.

Continuous Ambulatory Peritoneal Dialysis (CAPD) Market Remains Essential

Alongside APD, the continuous ambulatory peritoneal dialysis (CAPD) market continues to play a vital role in ESRD management. CAPD is a manual form of peritoneal dialysis in which patients perform several fluid exchanges throughout the day without the need for automated equipment.

CAPD offers several important benefits:

• No requirement for electricity or dialysis machines
• Greater accessibility in resource-limited settings
• Flexible home-based treatment
• Lower equipment costs
• Greater patient independence

Because CAPD can be performed in virtually any environment, it remains a preferred treatment option in many developing countries and rural healthcare settings. Ongoing improvements in dialysis solutions, catheter technologies, and infection prevention protocols continue to enhance treatment safety and patient outcomes.

Key Growth Drivers of the Peritoneal Dialysis Market

Several important factors continue to support the expansion of the global Peritoneal Dialysis Market.

Increasing prevalence of chronic kidney disease

The global rise in diabetes, hypertension, cardiovascular disease, and obesity has significantly increased the number of patients requiring long-term renal replacement therapy.

Growing preference for home-based dialysis

Patients and healthcare providers are increasingly choosing home dialysis because it offers greater convenience, reduced healthcare costs, and improved quality of life.

Technological advancements

Innovations in automated dialysis systems, remote patient monitoring, digital health platforms, and biocompatible dialysis solutions are improving treatment efficiency and patient safety.

Supportive healthcare policies

Many governments and healthcare organizations are promoting home dialysis programs to reduce hospital burden, improve patient outcomes, and lower overall healthcare expenditures.

These factors collectively continue to strengthen the long-term outlook for the Peritoneal Dialysis Market.

Discover the Complete Report Here:

https://www.polarismarketresearch.com/industry-analysis/peritoneal-dialysis-market

Key Companies

• Asahi Kasei Medical Co., Ltd. 
• AWAK Technologies
• B. Braun Melsungen AG 
• Baxter International 
• DaVita Inc. 
• Diaverum 
• Fresenius Kabi 
• Fresenius Medical Care 
• Huaren Pharmaceutical 
• JMS Co., Ltd. 
• Medionics International Inc. 
• Medtronic 
• Nipro Corporation 
• NxStage Medical, Inc. 
• Terumo Corporation 

Market Challenges

Despite favorable growth prospects, several challenges remain.

Peritoneal dialysis requires comprehensive patient education and consistent adherence to sterile procedures to reduce the risk of infections such as peritonitis. Limited awareness among patients and healthcare professionals may also affect treatment adoption in certain regions.

In addition, reimbursement variations, access to specialized nephrology services, and shortages of trained dialysis professionals can limit market growth, particularly in low-resource healthcare systems.

Regional Analysis

North America holds a significant share of the Peritoneal Dialysis Market due to advanced healthcare infrastructure, high chronic kidney disease prevalence, increasing adoption of home dialysis, and favorable reimbursement policies.

Europe continues to experience steady market growth, supported by established renal care programs, growing elderly populations, and strong government initiatives promoting home-based dialysis therapies.

Asia Pacific is expected to witness the fastest growth during the forecast period. Rising rates of diabetes and hypertension, expanding healthcare infrastructure, improving access to renal care, and increasing investments in dialysis services are driving strong market expansion across emerging economies.

Latin America and the Middle East & Africa are also experiencing gradual growth as governments improve access to kidney disease treatment and invest in expanding dialysis services.

Future Outlook

The future of the Peritoneal Dialysis Market is expected to be shaped by continued growth in the end stage renal disease (ESRD) treatment market, rapid expansion of the automated peritoneal dialysis (APD) market, and sustained demand within the continuous ambulatory peritoneal dialysis (CAPD) market. Innovations such as wearable dialysis technologies, artificial intelligence-assisted patient monitoring, telehealth integration, and next-generation biocompatible dialysis solutions are expected to further enhance patient outcomes and treatment efficiency.

More Trending Latest Reports By Polaris Market Research:

Gene Therapy Market

C-Reactive Protein Testing Market

Hospital Logistics Robots Market

US Cardiovascular Devices Market

Blood Plasma Market

Legionella Testing Market

Healthcare Analytical Testing Services Market

Antibody Contract Manufacturing Market